MFG
VIVO

Magnus Financial Group’s Meridian Bioscience Inc VIVO Stock Holding History

Magnus Financial Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,247
Closed -$136K – 777
2020
Q1 		$136K Sell
16,247
-4,183
-20% -$35.2K 0.02% 498
2019
Q4 		$200K Buy
+20,430
New +$192K 0.03% 507

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Magnus Financial Group's VIVO Position: Q2 2020 in Review

Magnus Financial Group sold out of Meridian Bioscience Inc (VIVO) in Q2 2020, closing a stake of 16,247 shares — an estimated $136K sold.

Magnus Financial Group first reported a position in VIVO in Q4 2019 and held it in 2 quarters. The position peaked at $200K in Q4 2019. 191 funds tracked by Wall St. Rank hold VIVO as of Q2 2020.

  • Magnus Financial Group reported no remaining Meridian Bioscience Inc position as of Q2 2020 after selling out during the quarter.
  • Magnus Financial Group sold 16,247 Meridian Bioscience Inc shares in Q2 2020, an estimated $136K.
  • Magnus Financial Group first reported a position in Meridian Bioscience Inc in Q4 2019 and held it in 2 quarters.
  • Magnus Financial Group's Meridian Bioscience Inc position peaked at $200K in Q4 2019.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2020.

Based on Magnus Financial Group's 13F filing for Q2 2020, filed 11 Aug 2020.